InvestorsHub Logo
Followers 3
Posts 288
Boards Moderated 0
Alias Born 12/21/2022

Re: None

Thursday, 06/29/2023 9:01:25 AM

Thursday, June 29, 2023 9:01:25 AM

Post# of 110
HC Wainwright upgraded shares of Black Diamond Therapeutics from a neutral rating to a buy rating in a research report sent to investors on Wednesday. The brokerage currently has $11.00 target price on the stock.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BDTX News